Type(s) of colorectal cancer (CRC)-Malignant polyp of colon Posts on Medivizor
Navigation Menu

Type(s) of colorectal cancer (CRC)-Malignant polyp of colon Posts on Medivizor

Unplanned readmission to hospital after colorectal surgery: how often does it happen and why?

Unplanned readmission to hospital after colorectal surgery: how often does it happen and why?

Posted by on Mar 30, 2015 in Colorectal cancer | 0 comments

In a nutshell This study examined how often and why patients are readmitted to hospital within 90 days of colorectal cancer surgery. Some background Treatment for colorectal cancer often involves surgery, which can be followed by chemotherapy. After a short recovery period in hospital most patients will continue their recovery at home....

Read More

Aspirin and colorectal cancer reviewed

Aspirin and colorectal cancer reviewed

Posted by on Mar 31, 2014 in Colorectal cancer | 0 comments

In a nutshell This review analyzed recent research investigating the effects of aspirin on colorectal cancer outcomes. Some background Aspirin is a common anti-inflammatory drug often used to relieve pain and reduce fever. The anti-inflammatory properties of aspirin are associated with its ability to inhibit the actions of the enzyme...

Read More

Differences between colon and rectal cancers

Differences between colon and rectal cancers

Posted by on Mar 6, 2014 in Colorectal cancer | 0 comments

In a nutshell This study analyzed data from the national cancer surveillance program in order to compare between the characteristics and outcomes of patients with colon and rectal cancer. Some background Colon and Rectal cancer are the third most common causes of cancer in the United States. The clinical presentation, diagnosis and treatment of...

Read More

New predictors of prognosis in colon cancer?

New predictors of prognosis in colon cancer?

Posted by on Feb 18, 2014 in Colorectal cancer | 0 comments

In a nutshell The current study examined whether the proteins versican and lumican were predictive of prognosis among colon cancer patients. Some background Colon cancer treatments vary depending on the type and stage of the disease. Patients with advanced cancer, which has invaded the surrounding lymph nodes, usually receive chemotherapy along...

Read More

Overall survival gain with the addition of aflibercept to standard chemotherapy

Overall survival gain with the addition of aflibercept to standard chemotherapy

Posted by on Jan 16, 2014 in Colorectal cancer | 0 comments

In a nutshell This study estimated survival gain with the addition of aflibercept (Zaltrap) to standard chemotherapy among patients with metastatic colorectal cancer. Some background A combination chemotherapy regimen referred to as FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) is considered the standard of care in the treatment of...

Read More

Combination of capecitabine and bevacizumab

Combination of capecitabine and bevacizumab

Posted by on Jan 3, 2014 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the use of capecitabine in combination with bevacizumab (Avastin) in the treatment of unresectable metastatic colorectal cancer. Some background Current treatment of unresectable metastatic colorectal cancer (wide spread cancer that cannot be removed by surgery do to size or location) includes chemotherapy, such...

Read More

Diet and colorectal cancer

Diet and colorectal cancer

Posted by on Dec 18, 2013 in Colorectal cancer | 0 comments

In a nutshell This review explored the relationship between dietary supplements and colorectal cancer outcomes. Some background The prevalence of colorectal cancer has steadily increased over the past 50 years. Dietary changes and decreased physical activity have led to an obesity epidemic in the western world, a known risk factor for many...

Read More

Can physical activity improve survival?

Can physical activity improve survival?

Posted by on Oct 18, 2013 in Colorectal cancer | 0 comments

In a nutshell This trial investigated the association between physical activity and the risk of recurrence (return of the cancer) and survival in patients with colon cancer (cancer of the large intestine). Some background The treatments of colon cancer have improved significantly over the years. However, many patients still have high risks for...

Read More

Treating unresectable liver metastasis

Posted by on Sep 15, 2013 in Colorectal cancer | 0 comments

In a nutshell This study investigated the combination of hepatic artery infusion (HAI) and systemic chemotherapy for the treatment of unresectable colorectal cancer liver metastasis (CRLM). Some background The liver is the most common site of metastasis (cancer spread) in colorectal cancer patients. Surgical treatments that remove all liver tumors...

Read More